Niagen Bioscience Inc
USD3.23
-0.07 (-2.27%)
CEO
Robert N. Fried
IPO Date
2015-06-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.28
Prev. Close
$3.30
Day Low
$3.18
Day High
$3.28
52W Low
$3.18
52W High
$14.40
Market Cap
$0.26B
Volume
0.26M
| 31,746 |
| $3.45 |
| 26 Jun 2026 | Cohen Ann | director | A-Award | Acquired | 31,746 | $3.45 |
| 26 Jun 2026 | Patrick Kristin | director | A-Award | Acquired | 31,746 | $3.45 |
| 26 Jun 2026 | Shahbazi Hamed | director | A-Award | Acquired | 31,746 | $3.45 |
| 26 Jun 2026 | Rubin Steven D | director | A-Award | Acquired | 31,746 | $3.45 |
| 26 Jun 2026 | Jaksch Frank L Jr | director | A-Award | Acquired | 31,746 | $3.45 |
| 27 Apr 2026 | Fried Robert N | director, officer: Chief Executive Officer | M-Exempt | Acquired | 20,000 | $2.61 |
| 27 Apr 2026 | Fried Robert N | director, officer: Chief Executive Officer | M-Exempt | Disposed | 20,000 | $2.61 |
| 24 Feb 2026 | Lopez Carlos Luis | SVP, General Counsel | A-Award | Acquired | 41,420 | $4.94 |